Do you offer local treatment to the breast primary in patients with de novo oligometastatic hormone positive breast cancer?

The E2108 study by Khan et al., showed that early local therapy in de-novo metastatic BC did not improve PFS/OS, and in fact showed worse OS in the small subset of TNBC in the study (20 patients). Although there was improved locoregional control in the local therapy arm, there was no quality of life...